Minimize Uncertainty – Make Informed Decisions – Succeed

ACC 2026 Preview: Key Cardiology Highlights to Watch

March 31, 2026Our Insights,strategycardiology,clinical trials,HEART FAILURE,Conference Previews,prevention,american college of cardiology,Interventional cardiology,Pharma CI,Insights,CardioAI,AI-Driven Healthcare,ACC 2026

ACC 2026 at a Glance Get ready for ACC 2026. LucidQuest’s preview highlights…

by Matina Laloumi

Endocrinology

Endocrinology Today—March 31, 2026

March 31, 2026Endocrinology News,Diabetes UKsemaglutide,Continuous Glucose Monitoring,Insilico Medicine,BetterMe,BioPharma and Tech News,Continuity Biosciences,Novo Nordisk,NICHE,diabetes,Breakthrough Type 1 Diabetes,Eli Lilly,Awiqli,type 2 diabetes,Hetero,type 1 diabetes,Glucotrack,Acromegaly,Crinetics Pharmaceuticals,insulin icodec,BILDYOS,Denosumab,TUZEMTY,Paltusotine,PALSONIFY,Henlius

This week’s Endocrinology update highlights regulatory progress, access…

by LucidQuest

Obesity Weekly News

Obesity Today—March 31, 2026

March 31, 2026Imcivree,WVE-007,wegovy,Samchundang Pharma,semaglutide,VIVUS,BioPharma and Tech News,QSIVA,obesity,Phentermine/Topiramate,Novo Nordisk,type 2 diabetes,Viking Therapeutics,VK2735,Setmelanotide,Obesity News,Wave Life Sciences,UBT251Rhythm Pharmaceuticals,Acquired Hypothalamic Obesity

This week’s Obesity update highlights regulatory progress, advancing late-stage…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804

March 31, 2026clinical trials,reimbursement,immunology,psoriatic arthritis,Ulcerative Colitis,Autoimmune Disease,Crohns Disease,biopharma,Johnson & Johnson,Lucid Diligence Brief,payer access,Royalty Pharmaroyalty financing

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…

by Timos Papagatsias

Hematology

Hematology Today—March 30, 2026

March 30, 2026Hematology News,Polatuzumab VedotinLarge B-cell lymphoma,Multiple Myeloma,Equecabtagene autoleucel,Elranatamab,Chronic myeloid leukemia,Hemophilia A,Philadelphia chromosome positive acute lymphoblastic leukemia,BioPharma and Tech News,Kamada,Daratumumab,Hympavzi,hemophilia b,Marstacimab,Darzalex,cemsidomide,Selinexor,relapsed refractory multiple myeloma,myelofibrosis,TERN-701,Eque-cel,Sarclisa,Lunsumio,Isatuximab,mosunetuzumab,Iclusig,Acute Myeloid Leukemia,Ponatinib,ruxolitinib,Polivy

This week’s Hematology update highlights regulatory progress, evolving…

by LucidQuest

Onco_background

Oncology Today—March 30, 2026

March 30, 2026muscle-invasive bladder cancer,Theriva Biologics,Extensive stage small cell lung cancer,VCN-01,astellas,PharmaMar,Metastatic Pancreatic Ductal Adenocarcinoma,gsk,Gastrointestinal stromal tumor,Lenvima,BioPharma and Tech News,Siren Biotechnology,Lenvatinib,Keytruda,Recurrent High-Grade Glioma,Welireg,Small Cell Lung Cancer,Risvutatug Rezetecan,Belzutifan,Nuvation Bio,SRN-101,Renal Cell Carcinoma,taletrectinib,Zepzelca,PADCEV,Deciphera,ROS1-Positive Non-Small Cell Lung Cancer,Enfortumab Vedotin,Ono Pharmaceutical,TRIANA Biomedicines,pembrolizumab,TRI-611,Eisai,ALK-Positive Non-Small Cell Lung Cancer,lurbinectedin,Alphamab Oncology,Oncology News,AnbenitamabHER2-positive breast cancer,Ripretinib

This week’s Oncology update highlights regulatory momentum, late-stage clinical…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 30, 2026

March 30, 2026European XFEL,HiCardi,SLAC National Accelerator Laboratory,Doctor Eye CVD,remote patient monitoring,Lunai Bioworks,CareSens Air,Insilico Medicine,Clemann Group,Symptom Radar,BioPharma and Tech News,Noah Labs,Healing Index,Oura,Alnylam Pharmaceuticals,TRIBE V2,Philips,Neurophet,KongMing Model,Mayo Clinic,Dong-A ST,Large Language Models,cardiac amyloidosis,eMed,Multimodal AI,Blood–brain barrier,OpenAI Foundation,Wearable Biomarkers,AI in Healthcare and Digital Health,MIT,Coulomb Explosion Imaging,OpenEvidence,University Of Pennsylvania,Chronic Obstructive Pulmonary Disease Rehabilitation,meta,MOLEXA,Dementia Speech Screening,Neovascular age related macular degeneration,Pharma.AI,Continuous Glucose Monitoring,EchoNavigator R5.0Tenacia Biotechnology,DeviceGuide

This week’s Artificial Intelligence and Digital Health update highlights…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: InSilico Medicine and Lilly global partnership

March 30, 2026biotech,drug development,Insilico Medicine,Eli Lilly,Lucid Diligence Brief,metabolic disease,diligence,AI drug discovery,licensing deal,preclinical assets,business development,Hong Kong biotechplatform validation

Lucid Diligence Brief: InSilico Medicine and Lilly global partnership…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Otsuka to acquire Transcend Therapeutics

March 29, 2026clinical trials,market access,Regulatory,neuroscience,biopharma,PTSD,Lucid Diligence Brief,diligence,M&A,psychiatryneuroplastogen

Lucid Diligence Brief: Otsuka to acquire Transcend Therapeutics Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in COPD

March 28, 2026Respiratory,clinical trials,market access,biologics,Regulatory,astrazeneca,COPD,biopharma,Tozorakimab,Lucid Diligence Brief,payer accessdiligence

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in……

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Pinnacle Medicines $89 million Series B

March 27, 2026biotech,venture capital,clinical trials,immunology,Lucid Diligence Brief,diligence,platform biotech,AI drug discovery,cardiometabolic,drug delivery,oral peptidesprivate financing

Lucid Diligence Brief: Pinnacle Medicines $89 million Series B Professional…

by Timos Papagatsias

Respiratory

Respiratory Today—March 27, 2026

March 27, 2026Allergic Rhinitis,Avalyn Pharma,Asthma,AP01,Sandoz,Inhaled Pirfenidone,BioPharma and Tech News,AP02,Beam Therapeutics,Inhaled Nintedanib,Shionogi,ARIKAYCE,COVID-19,Amikacin Liposome Inhalation Suspension,Idiopathic Pulmonary Fibrosis,Mycobacterium Avium Complex Lung Disease,Respiratory News,BEAM-302,SARS-CoV-2,XOCOVA,chronic obstructive pulmonary disease,Ensitrelvir,zydus lifesciences,Azelastine Fluticasone,Insmed,Aerolife Mini,Alpha-1 antitrypsin deficiency,Interna TherapeuticsProgressive pulmonary fibrosis,MNM-siRNA

This week’s Respiratory update highlights clinical trial progress, regulatory…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.